 |
|
News and Publications
Press Release
The Scripps Research Institute/Genomics Institute for the Novartis Research Foundation
University of California, San Diego/San Diego Supercomputer Center
Stanford University/Stanford Synchrotron Radiation Laboratory
For information:
Robin B. Goldsmith
858-784-8134
kmckeown@scripps.edu
David Hart
858-534-8314
dhart@sdsc.edu
Kim McDonald
858-534-7572
kimmcdonald@ucsd.edu
P.A. Moore
650-926-2605
xanadu@slac.stanford.edu
New Genomic Center Funded To Advance HighThroughput Protein Structure Determination
La Jolla and Stanford, Calif., September 26, 2000 -- To deliver on the promise
of the genome project for health care, scientists must understand the information
implicit in the genome, specifically, the functions of the proteins encoded by
the genes. The Joint Center for Structural Genomics (JCSG), a consortium of California
scientific research organizations, has received a National Institutes of Health
(NIH) grant of $24 million over a five-year period to expand on the body of knowledge
made available by the completion of the human and other genome sequencing projects.
Its goal is to determine the three-dimensional structure of up to 2000 proteins
by developing state-of-the-art high-throughput technology, thereby advancing
efforts to understand structure-function relationships important for diseases
and their treatments.
The main organizations comprising the JCSG consortium are: The Scripps Research
Institute (TSRI)/ Genomics Institute for the Novartis Research Foundation (GNF);
University of California, San Diego (UCSD)/San Diego Supercomputer Center (SDSC);
and Stanford University/Stanford Synchrotron Radiation Laboratory (SSRL, a Division
of the Stanford Linear Accelerator Center, SLAC). Associated with the JCSG are
also 29 scientific collaborators from other institutions around the world, including
The Salk Institute and Syrrx Inc. in La Jolla.
Principal investigator Ian Wilson, D.Phil., Professor, Department of Molecular
Biology and The Skaggs Institute for Chemical Biology at TSRI, said, "This initiative
in structural genomics is the next step beyond the sequencing of the human and
other genomes and an opportunity to gain a more profound understanding of how
individual proteins work in the body. The consortium represents a close synergy
between academic and research institutions, along with their biotechnology partners,
combining their expertise in a large-scale effort with enormous potential benefits." Co-principal
investigator of the Center is John Wooley, Ph.D., Associate Vice Chancellor,
Research, UCSD. Dr. Wooley and other senior investigators at UCSD will direct
the bioinformatics component for JCSG. Said Dr. Wooley, "Today biology is a data-driven
science and bioinformatics is the sine qua non of modern biology. Data emerging
from this project will provide us comprehensive knowledge in atomic detail of
the molecular machines that drive cellular processes."
There are five major steps in high-throughput protein structure determination:
- Selection of the best protein targets
- Expression and purification of proteins
- Crystallization of proteins
- Collection of x-ray diffraction data
- Structure determination at high resolution
The primary aim of the JCSG is to develop and integrate high-throughput robotic
technologies for these steps, ultimately providing us with key insights about
biological function. Automating each step is JCSG's goal for its contribution
to the NIH target of 10,000 protein structures in ten years. "Structural genomics
has the potential to impact contemporary biology in a significant way by building
on the foundation of the sequencing genome projects," Wilson said. For rapid,
efficient, cost- effective determination of novel protein structures through
advances in experimental and computational methods, JCSG has established three
collaborative teams. The bioinformatics team directs target selection, informatics,
and validation; the crystallomics team is responsible for production of protein
samples and crystallization; the structure determination team orchestrates x-ray
data collection and analysis, structure determination, and refinement.
The initial focus of the JCSG will be on the complete worm (C. elegans) genome
and its 18,000 genes to provide a suitable number of targets to optimize each
component of the system. The JCSG's target selection committee is chaired by
Susan Taylor, Ph.D., Professor of Chemistry and Biochemistry at UCSD and HHMI
Investigator. "We will focus on proteins implicated in cell signaling information
transmission within and between cells," she said, "because these provide clues
to many aspects of disease. Using C. elegans signaling proteins as templates,
JCSG will investigate genetically related proteins in fruitfly (Drosophila),
mouse and human. Bioinformatics will be essential to identify the most promising
targets and ascertain genetically related proteins among the various organisms.
For protein expression, purification and crystallization, JCSG will use breakthrough
robotic technologies pioneered by Peter Schultz and Raymond Stevens at the Genomics
Institute of the Novartis Research Foundation, Lawrence Berkeley National Laboratory
and Syrrx, Inc. JCSG will also incorporate SSRL's novel technologies for synchrotron-based
data collection and structure solution. Similarly, JCSG will develop new structural
bioinformatics methods, exploiting SDSC cutting edge research in the Biology
WorkBench, the Protein Data Bank, the Storage Resource Broker and other informatics
activities. In addition to improving and integrating these technologies, JCSG
will construct new systems resulting in a complete, highly automated "pipeline" within
a knowledge-based feedback system.
A key enabling technology for the high-throughput structure determination
component is the combination of synchrotron x-rays and robotic crystal mounting
being developed at SSRL and the Advanced Light Source (ALS), Berkeley. According
to Keith Hodgson, Ph.D., Professor and Director of SSRL, " Synchrotron-based
macromolecular crystallography has revolutionized our ability to determine structures
with much higher quality and at a much faster rate than before. It is a particular
privilege and honor that SSRL will be one of the key partners in the JCSG. SSRL
was the site of the first pioneering protein crystallography experiments in the
mid-to-late seventies, and we look forward to helping the JCSG reach its goal
of high-throughput structure determination as a means to remarkable discoveries
in the biological and biomedical sciences."
The JCSG will build on the foundation its members and collaborators have
already laid in high- throughput protein expression, purification, crystallization
and crystallographic data collection and analysis. According to Wilson, "We expect
to refine essential tools and develop new ones; such progress is imperative for
the successful operation of a second-generation structural genomics center that
can exploit the tremendous opportunities in structural biology and medicine that
arise from the sequencing of the human genome."
Genes are the blueprint, whereas the proteins they encode are the workers,
the molecular machinery, in all living organisms. They digest food; provide us
with energy; allow the blood to carry oxygen; fight infections; enable us to
think, reason and speak; and perform many other critical activities. A protein's
function depends on the exquisitely fine details of its structure and shape --
the grooves, ridges, and pockets on or near its surface. By studying thousands
of molecules in this project, researchers will deepen their understanding of
how protein structure and function are interrelated. Scientists will better understand
how each protein functions normally, and how defective proteins malfunction and
cause disease. Ultimately, this knowledge will lead to new diagnostic techniques
and therapeutics.
The JCSG is funded by the National Institutes of General Medical Science
(NIGMS,), one of the main supporters of basic biomedical research within the
National Institutes of Health (NIH). NIGMS is funding seven such projects throughout
the U.S.; the Joint Center for Structural Genomics is one of three such centers
in the Western U.S. NIGMS anticipates spending a total of $140 to $175 million
over five years. According to NIGMS Director, Marvin Cassman, "This project can
be viewed as an inventory of all the protein structure families that exist in
nature. We expect that this effort will yield major biological findings that
will shed light on health and disease." Preliminary results laying the foundation
for the centers were supported by the NIH, the National Science Foundation (NSF),
the Department of Energy Office of Biological and Environmental Research (DOE-BER),
the Genomics Institute for the Novartis Research Foundation and Syrrx Inc. Hodgson
noted " All seven new centers will use synchrotron radiation, an essential component
of these technologies made available only because of the sustained funding provided
by DOE and NSF in operating these user facilities."
URLs for further information:
Joint Center for Structural Genomics: http://www.jcsg.org
The Scripps Research Institute: http://www.scripps.edu
The University of California San Diego: http://www.ucsd.edu
San Diego Supercomputer Center: http://www.sdsc
Stanford Synchrotron Radiation Laboratory: http://www-ssrl.slac.stanford.edu
National Institutes of General Medical Sciences: http://www.nigms.nih.gov
For more information contact:
Keith McKeown
10550 North Torrey Pines Road
La Jolla, California 92037
Tel: 858.784.8134
Fax: 858.784.8118
kmckeown@scripps.edu
Copyright © 2000 TSRI.
All rights reserved. Reproduction in whole or in part in any form or medium without express written permission of TSRI is prohibited.
|
|